ARTICLE | Company News
Casigen Pharma, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences deal
May 21, 2012 7:00 AM UTC
The institute granted newco Casigen an exclusive, worldwide license to small molecules for diabetes and other metabolic disorders. The preclinical products target estrogen-related receptor alpha (ERR-...